Anavex Life Sciences Corp (AVXL)

[attilathehunt]

"Meanwhile, FDA’s Kun Jin, after more than 27 years at the agency, was named VP and head of biostatistics at Anavex Life Sciences in March. And earlier this week, Biohaven, a clinical-stage biopharma company, named Nick Kozauer, former acting deputy director of the FDA’s Division of Neurology Products and eight-year FDA vet, as SVP for clinical development and regulatory strategy. "


The issue is we need to see the data. enough of the BS from Chris....No wonder they removed BOD from his title. I hope CEO title is next.